Medicinal Research Reviews
Medicinal Research Reviews is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 157. It has a price of 2750 €. It has an SJR impact factor of 3,169 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,169.
Medicinal Research Reviews focuses its scope in these topics and keywords: drug, targeting, advances, receptor, cancer, binding, agentsrecent, natural, affinity, pglycoprotein, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
3,169
H-index
157
Docs (year)
80
Docs 3y
217
Total refs
16217
Cites 3y
3278
Citable 3y
214
Cites/Doc 2y
15.18
Ref/Doc
202.71
Immediate OA
2750 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Carbonic anhydrase inhibitors
Click chemistry reactions in medicinal chemistry: Applications of the 1,3-dipolar cycloaddition between azides and alkynes
Flavonoids: Promising anticancer agents
The art and practice of structure-based drug design: A molecular modeling perspective
Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Antioxidant and other biological activities of phenols from olives and olive oil
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Multicomponent domino reactions for the synthesis of biologically active natural products and drugs
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
New developments in the chemistry and biology of the bioactive constituents of tanshen
Combining docking and molecular dynamic simulations in drug design
Anti-cancer properties of anthraquinones from rhubarb
Boronic acid compounds as potential pharmaceutical agents
New insights on the anticancer properties of dietary polyphenols
Recent progress in the development of coumarin derivatives as potent anti-HIV agents
Drugs that target dynamic microtubules: A new molecular perspective
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Bionanotechnology based on silica nanoparticles
Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection
The thioredoxin system?From science to clinic
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers